FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients

Abstract Background Forkhead box A1 (FOXA1) expression is associated with various types of tumors; however, the function and underlying mechanism of FOXA1 in the development of hepatocellular carcinoma (HCC) remains obscure. Methods Here, we investigated the role of FOXA1 in the development of HCC b...

Full description

Bibliographic Details
Main Authors: Shujiao He, Junyi Zhang, Wan Zhang, Fengsheng Chen, Rongcheng Luo
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-017-0646-6
_version_ 1818126338591031296
author Shujiao He
Junyi Zhang
Wan Zhang
Fengsheng Chen
Rongcheng Luo
author_facet Shujiao He
Junyi Zhang
Wan Zhang
Fengsheng Chen
Rongcheng Luo
author_sort Shujiao He
collection DOAJ
description Abstract Background Forkhead box A1 (FOXA1) expression is associated with various types of tumors; however, the function and underlying mechanism of FOXA1 in the development of hepatocellular carcinoma (HCC) remains obscure. Methods Here, we investigated the role of FOXA1 in the development of HCC by applying gene function gain and loss analysis to HepG2 and Hep3B cell lines, and comparing outcomes with those of clinical HCC samples. Results Phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1), which encodes protein PI3Kp85 (p85), was identified as a FOXA1 target gene. Analyses of the mechanism and function revealed that FOXA1 suppresses hepatocellular carcinoma cell viability and motility by inhibiting PI3K/Akt signaling through direct inhibition of PIK3R1 transcription. Moreover, in clinical samples from male HCC patients, FOXA1 expression was much lower, whereas PI3Kp85 levels were much higher in tumor than in non-tumor tissues. Elevated PI3Kp85 is an unfavorable factor in HCC. Conclusions As a tumor suppressor, FOXA1 targets PIK3R1 directly to inhibit PI3K/Akt signaling pathway, thus exerting a negative regulatory effect on proliferation, migration, and invasion of HCC in male patients.
first_indexed 2024-12-11T06:59:53Z
format Article
id doaj.art-2e7eed3a6373493e8e7b50fe70029c60
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-11T06:59:53Z
publishDate 2017-12-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-2e7eed3a6373493e8e7b50fe70029c602022-12-22T01:16:39ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662017-12-0136111010.1186/s13046-017-0646-6FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patientsShujiao He0Junyi Zhang1Wan Zhang2Fengsheng Chen3Rongcheng Luo4Cancer Center, Southern Medical UniversityCancer Center, Southern Medical UniversityCancer Center, Southern Medical UniversityCancer Center, Southern Medical UniversityCancer Center, Southern Medical UniversityAbstract Background Forkhead box A1 (FOXA1) expression is associated with various types of tumors; however, the function and underlying mechanism of FOXA1 in the development of hepatocellular carcinoma (HCC) remains obscure. Methods Here, we investigated the role of FOXA1 in the development of HCC by applying gene function gain and loss analysis to HepG2 and Hep3B cell lines, and comparing outcomes with those of clinical HCC samples. Results Phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1), which encodes protein PI3Kp85 (p85), was identified as a FOXA1 target gene. Analyses of the mechanism and function revealed that FOXA1 suppresses hepatocellular carcinoma cell viability and motility by inhibiting PI3K/Akt signaling through direct inhibition of PIK3R1 transcription. Moreover, in clinical samples from male HCC patients, FOXA1 expression was much lower, whereas PI3Kp85 levels were much higher in tumor than in non-tumor tissues. Elevated PI3Kp85 is an unfavorable factor in HCC. Conclusions As a tumor suppressor, FOXA1 targets PIK3R1 directly to inhibit PI3K/Akt signaling pathway, thus exerting a negative regulatory effect on proliferation, migration, and invasion of HCC in male patients.http://link.springer.com/article/10.1186/s13046-017-0646-6FOXA1Hepatocellular carcinomaPIK3R1/PI3Kp85PI3K/Akt
spellingShingle Shujiao He
Junyi Zhang
Wan Zhang
Fengsheng Chen
Rongcheng Luo
FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
Journal of Experimental & Clinical Cancer Research
FOXA1
Hepatocellular carcinoma
PIK3R1/PI3Kp85
PI3K/Akt
title FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
title_full FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
title_fullStr FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
title_full_unstemmed FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
title_short FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
title_sort foxa1 inhibits hepatocellular carcinoma progression by suppressing pik3r1 expression in male patients
topic FOXA1
Hepatocellular carcinoma
PIK3R1/PI3Kp85
PI3K/Akt
url http://link.springer.com/article/10.1186/s13046-017-0646-6
work_keys_str_mv AT shujiaohe foxa1inhibitshepatocellularcarcinomaprogressionbysuppressingpik3r1expressioninmalepatients
AT junyizhang foxa1inhibitshepatocellularcarcinomaprogressionbysuppressingpik3r1expressioninmalepatients
AT wanzhang foxa1inhibitshepatocellularcarcinomaprogressionbysuppressingpik3r1expressioninmalepatients
AT fengshengchen foxa1inhibitshepatocellularcarcinomaprogressionbysuppressingpik3r1expressioninmalepatients
AT rongchengluo foxa1inhibitshepatocellularcarcinomaprogressionbysuppressingpik3r1expressioninmalepatients